Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05546229 · ClinicalTrials.gov registry record
Assessment of Methadone and Buprenorphine in Interstitial Fluid
A clinical trial of Opioid Use Disorder, sponsored by Cari Health.
- Completed
- Registry status
- 11
- Enrollment target
- 1
- Study location
NCT05546229 is a study of Opioid Use Disorder that has completed, run by Cari Health. The registered enrollment target is 11 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05546229, a study of Opioid Use Disorder, has completed, sponsored by Cari Health.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine if common medications for opioid use disorder (i.e., buprenorphine/naloxone, buprenorphine, methadone) and their metabolites (norbuprenorphine \[a metabolite of buprenorphine\], buprenorphine-3-glucuronide \[B3G; a metabolite in buprenorphine\], ethylidene dimethyl diphenyl pyrrolidine \[EDDP; a metabolite of methadone\]) can be detected in the dermal interstitial fluid (i.e., fluid extracted from the surface of the skin). Additional subjects who are not prescribed or taking any of these medications will be included in this study to act as a comparison group
Conditions Studied
Interventions
- PROCEDURE Microneedle based interstitial fluid collection
Study Locations (1)
California
- Synergy San Diego - Lemon Grove
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2022-09-14 |
| Est. Completion | 2022-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05546229
The ClinicalTrials.gov registry entry for NCT05546229 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is Cari Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Microneedle based interstitial fluid collection is the first listed.
NCT05546229 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05546229 about?
NCT05546229 is a clinical study titled "Assessment of Methadone and Buprenorphine in Interstitial Fluid". The purpose of this research is to determine if common medications for opioid use disorder (i.e., buprenorphine/naloxone, buprenorphine, methadone) and their metabolites (norbuprenorphine \[a metabolite of buprenorphine\], buprenorphine-3-glucuronide \[B3G; a metabolite in buprenorphine\], ethyliden...
What is the current status of trial NCT05546229?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2022-09-14. Estimated completion is 2022-10-31.
What conditions does trial NCT05546229 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT05546229?
The interventions under investigation include: Microneedle based interstitial fluid collection (PROCEDURE).
Who is sponsoring clinical trial NCT05546229?
This trial is sponsored by Cari Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05546229 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.